![Physiologically Based Pharmacokinetic Modeling for Olaparib Dosing Recommendations: Bridging Formulations, Drug Interactions, and Patient Populations - Pilla Reddy - 2019 - Clinical Pharmacology & Therapeutics - Wiley Online Library Physiologically Based Pharmacokinetic Modeling for Olaparib Dosing Recommendations: Bridging Formulations, Drug Interactions, and Patient Populations - Pilla Reddy - 2019 - Clinical Pharmacology & Therapeutics - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/13cd339c-21d8-4c51-861d-15c8f15fc885/cpt1103-fig-0001-m.jpg)
Physiologically Based Pharmacokinetic Modeling for Olaparib Dosing Recommendations: Bridging Formulations, Drug Interactions, and Patient Populations - Pilla Reddy - 2019 - Clinical Pharmacology & Therapeutics - Wiley Online Library
![Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients | SpringerLink Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-018-0714-x/MediaObjects/40262_2018_714_Fig1_HTML.png)
Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients | SpringerLink
![Adverse events in women switching from olaparib capsules to tablets: retrospective observational study of US claims data | Future Oncology Adverse events in women switching from olaparib capsules to tablets: retrospective observational study of US claims data | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2020-0142/asset/images/medium/figure1.gif)
Adverse events in women switching from olaparib capsules to tablets: retrospective observational study of US claims data | Future Oncology
![Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and Expectations. - Abstract - Europe PMC Administration of the Tablet Formulation of Olaparib in Patients with Ovarian Cancer: Practical Guidance and Expectations. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6067940/bin/onco12425-fig-0002.jpg)